Ammonia oxidizing microorganism therapeutics: Skin MicrobiomeLast 5 Years Research Landscape
Skin microbiome depletion of Nitrosomonas species prevents natural nitric oxide production, necessitating specialized stabilization and delivery systems for live ammonia-oxidizing bacteria.
What technical problems is Skin Microbiome addressing in Ammonia oxidizing microorganism therapeutics?
Inflammatory acne pathology
(6)evidences
Ammonia oxidizing bacteria struggle to maintain therapeutic nitric oxide levels required to suppress inflammatory skin conditions like acne.
Microbiome formulation incompatibility
(6)evidences
Standard consumer product ingredients inhibit the growth of beneficial ammonia oxidizing microorganisms, leading to microbiome dysbiosis.
Aom shelf stability
(5)evidences
Live Nitrosomonas cultures exhibit rapid viability loss in topical preparations, preventing effective long-term restoration of the skin microbiome.